[Microbiology Spectrum] Researchers identified a stably integrated and transcriptionally active anellovirus genome in anAML cell line, providing a unique model to study viral persistence in hematopoietic cells.
[Blood Advances] Scientists showed that CD55 protects hematopoietic stem and progenitor cells from complement-mediated damage in aplastic anemia, highlighting complement inhibition as a potential therapeutic strategy
[Nature Communications] Using murine models and human mixed lineage leukemia (MLL)-r leukemia cells, the authors showed that the FA pathway suppresses leukemogenesis by limiting error-prone non-homologous end joining-mediated genomic instability.
[Blood] By screening the nucleoporin (NUP) family, scientists identified NUP214 as a frequently overexpressed gene and a critical fitness determinant in leukemia stem cells (LSCs). NUP214 acts as a conserved driver of LSC survival by restricting heme catabolism, limiting Fe²⁺ accumulation, and suppressing lipid peroxidation.
[Leukemia] Researchers identified the RNA splicing factor PTBP1 as a key dependency in acute myeloid leukemia, sustaining leukemia by controlling the processing of essential oncogenic transcripts.
[Leukemia] Investigators mapped purinergic signaling at single-cell resolution in human cord blood stem and progenitor cells, revealing how ATP and adenosine pathways are organized across early blood cell development.
[Nature Reviews Gastroenterology & Hepatology] Expanding preclinical and clinical literature from PDAC and other oncological indications identifies novel approaches through which radiation therapy–immunotherapy combinations could improve local and systemic disease control in patients with PDAC.
[US FDA] The US FDA approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule.